新生儿弥散性血管内凝血的治疗(4)
[29] Davis-Jackson R， Correa H， Horswell R， et al.Antithrombin III(AT) and recombinant tissue plasminogen activator(R-TPA) used singly and in combination versus supportive care for treatment of endotoxin-induced disseminated intravascular coagulation(DIC) in the neonatal pig[J]. Thromb J， 2006， 4(8)：7.
[30]宋善俊.弥散性血管内凝血诊疗指南[J].继续医学教育， 2006， 20(4)：9-15.
[31] Forbes T J， Hijazi Z M， Young G， et al. Pediatric catheterization laboratory anticoagulation with bivalirudin[J]. Catheter Cardiovasc Interv， 2011， 77(5)：671-679.
[32] Ezzat W H， Dahl J P， Luginbuhl A， et al. Recombinant human tissue factor pathway inhibitor prevents thrombosis in a venous tuck model[J]. Laryngoscope， 2010， 120(11)： 2172-2176.
[33] Van Den Boogaard F E， Brands X， Schultz M J， et al.Recombinant human tissue factor pathway inhibitor exerts anticoagulant， anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia[J]. J Thromb Haemost， 2011， 9(13)：122-132.
(收稿日期：2014-01-05) (编辑：黄新珍), 百拇医药(郑文明 李清平)
[30]宋善俊.弥散性血管内凝血诊疗指南[J].继续医学教育， 2006， 20(4)：9-15.
[31] Forbes T J， Hijazi Z M， Young G， et al. Pediatric catheterization laboratory anticoagulation with bivalirudin[J]. Catheter Cardiovasc Interv， 2011， 77(5)：671-679.
[32] Ezzat W H， Dahl J P， Luginbuhl A， et al. Recombinant human tissue factor pathway inhibitor prevents thrombosis in a venous tuck model[J]. Laryngoscope， 2010， 120(11)： 2172-2176.
[33] Van Den Boogaard F E， Brands X， Schultz M J， et al.Recombinant human tissue factor pathway inhibitor exerts anticoagulant， anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia[J]. J Thromb Haemost， 2011， 9(13)：122-132.
(收稿日期：2014-01-05) (编辑：黄新珍), 百拇医药(郑文明 李清平)